• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHAO Chen,YANG Yiwen,WANG Hongping,PENG Ping,YIN Qiong,XIAO Tingting,XU Yiqiao.Efficacy mining and zebrafish experiment verification of efficacy of Wuzi Yanzong Pill[J].Journal Of Pharmaceutical Research,2024,43(3):227-231,242[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3043times   Download 3163次 QR Code for this article
Scan with your phone!
五子衍宗丸的药效挖掘及斑马鱼实验验证
赵晨1,杨怡雯2,王洪平1,彭平1,尹琼1,肖婷婷1,徐懿乔2
Font:Larger+|Default|Smaller-
(1.北京同仁堂股份有限公司科学研究所,北京 100079;2.杭州环特生物科技股份有限公司,浙江 杭州 310051)
摘要:
目的 研究药物与疾病的关联并利用斑马鱼模型加以验证,挖掘五子衍宗丸潜在的适应症。方法 收集五子衍宗丸活性成分及靶点,通过组织特异性和药物-疾病通路关联分析确定研究方向,基于模式生物斑马鱼进行活体试验验证。结果 收集五子衍宗丸相关靶点1 441个,靶点作用部位可能与神经系统、生殖、代谢、癌症以及肾脏功能等相关。药物-疾病通路关联分析表明,阿尔茨海默症和糖尿病为五子衍宗丸潜在研究方向。斑马鱼降糖药效试验表明,五子衍宗丸可以降低斑马鱼葡萄糖水平并改善糖尿病神经病变。防治阿尔茨海默病药效试验表明,五子衍宗丸可以改善斑马鱼反应能力,恢复运动功能,可能与抑制乙酰胆碱酯酶活性有关。结论 将计算二次开发的方法和生物验证相结合,发现五子衍宗丸对糖尿病及阿尔茨海默病有一定的治疗效果,为五子衍宗丸的二次开发提供了参考。
关键词:  五子衍宗丸  斑马鱼  糖尿病  活性成分  阿尔茨海默病
DOI:10.13506/j.cnki.jpr.2024.03.004
基金项目:北京市科技计划(No.Z201100005420005)
Publication Date:March 25, 2024
Efficacy mining and zebrafish experiment verification of efficacy of Wuzi Yanzong Pill
ZHAO Chen1,YANG Yiwen2,WANG Hongping1,PENG Ping1,YIN Qiong1,XIAO Tingting1,XU Yiqiao2
(1.Scientific Research Institute, Beijing Tongrentang Co., Ltd., Beijing 100079,China; 2. Hangzhou Hunter Biotechnology Inc., Hangzhou 310051,China)
Abstract:
Objective To study the association between drugs and diseases and to explore the potential indications of Wuzi Yanzong Pill by using zebrafish model. Methods The active ingredients and targets of Wuzi Yanzong Pill were collected, and the research direction was determined by tissue specificity and drug-disease pathway association analysis. In vivo experiments were conducted based on model biological zebrafish. Results 1 441 targets related to Wuzi Yanzong Pill were collected. The target sites may be related to nervous system, reproduction, metabolism, cancer, kidney function, etc. The correlation analysis of drug-disease pathway indicated that Alzheimer's disease and diabetes were potential research directions for Wuzi Yanzong Pill. The hypoglycemic efficacy test of zebrafish showed that Wuzi Yanzong Pill could reduce the glucose level of zebrafish and improve diabetic neuropathy. Efficacy test for prevention and treatment of Alzheimer's disease showed that Wuzi Yanzong Pill can improve the reaction ability of zebrafish and restore motor dysfunction, which may be related to the inhibition of acetylcholin esterase activity. Conclusion Combining the computational secondary development methods with the zebrafish activity experiment, it is found that Wuzi Yanzong Pill has certain therapeutic effect on diabetes and Alzheimer's disease, which provides reference for the secondary development of Wuzi Yanzong Pill.
Key words:  Wuzi Yanzong Pill  Zebrafish  Diabetes  Active ingredients  Alzheimer's disease
Today's Visits:527    Total Visits:2383269
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.